Health Canada inspection
Boehringer Ingelheim Pharma GmbH & Co. KG: Health Canada inspection of Oct 13, 2022
Health Canada · GMP · rating C
Key facts
| Establishment | Boehringer Ingelheim Pharma GmbH & Co. KG |
|---|---|
| City | Ingelheim Am Rhein |
| Province | Rhineland-Palatinate |
| Country | Germany |
| Program | GMP |
| Start date | Oct 13, 2022 |
| Rating | C |
| Rating description | Compliant |
| Licence number | Not applicable |
At a glance
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.